MedTrace Logo

Post-market Clinical Follow-up Study of Alcon TOTAL30® Contact Lenses (Lehfilcon A)

NCT06408649 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 129

Last updated 2025-07-20

No results posted yet for this study

Summary

The purpose of this Post-Market Clinical Follow-Up (PMCF) study is to continuously assess the visual performance and safety of TOTAL30 Sphere and TOTAL30 for Astigmatism contact lenses in a real-world setting across a broad variety of patients through routine clinical practices.

Conditions

  • Ametropia
  • Myopia
  • Hyperopia
  • Astigmatism

Interventions

DEVICE

Lehfilcon A spherical contact lenses

Silicone hydrogel contact lenses for the correction of ametropia (myopia or hyperopia)

DEVICE

Lehfilcon A toric contact lenses

Silicone hydrogel contact lenses for the correction of ametropia (myopia or hyperopia) with astigmatism

Sponsors & Collaborators

  • Alcon Research

    lead INDUSTRY

Principal Investigators

  • Clinical Trial Lead, Vision Care · Alcon Research, LLC

Eligibility

Min Age
7 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-15
Primary Completion
2025-04-22
Completion
2025-04-22
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06408649 on ClinicalTrials.gov